We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Vitamin D Insufficiency Linked to Development of Crohn's Disease

By LabMedica International staff writers
Posted on 09 Feb 2010
Print article
Results published in a recent paper suggest that supplementing the diet with vitamin D can protect against development of Crohn's disease, a chronic incurable inflammatory bowel condition.

Vitamin D signaling through the vitamin D receptor has emerged as a key regulator of innate immunity in humans. Investigators at McGill University (Montreal, Canada) extended this observation to the serious autoimmune syndrome known as Crohn's disease.

They reported in the January 22, 2010, edition of the Journal of Biological Chemistry that vitamin D acted directly to stimulate two genes that could be related to the development of Crohn's disease. The first, the beta defensin 2 gene, encodes an antimicrobial peptide that interacts with intestinal bacteria. The second, the NOD2 gene, alerts immune cells to the presence of invading microbes. When vitamin D levels were insufficient, these two genes malfunctioned, which induced the type of inflammatory response found in Crohn's disease.

"Our data suggests, for the first time, that vitamin D deficiency can contribute to Crohn's disease," said Dr. John White, professor of physiology at McGill University. "It is a defect in innate immune handling of intestinal bacteria that leads to an inflammatory response that may lead to an autoimmune condition."

"Siblings of patients with Crohn's disease that have not yet developed the disease might be well advised to make sure they are vitamin D sufficient," said Dr. White. "It is something that is easy to do, because they can simply go to a pharmacy and buy vitamin D supplements. The vast majority of people would be candidates for vitamin D treatment."

Related Links:

McGill University


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultrasonic Cleaner
UC 300 Series
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: A one-step confirmatory laboratory test could definitively diagnose active syphilis infection within 10 minutes (Photo courtesy of Adobe Stock)

First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes

In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more